Within a large group of more than 700 patients treated with CAR T cell therapy, researchers found no evidence that the therapy itself caused any type of secondary cancer in the modified T cells, ...
Ryan Weikert, Chief Product Officer, joins WMS with extensive product innovation expertise. He has 25 years of experience in telecommunications product development, roaming, marketing, and business ...